Associate Professor of Medicine, Massachusetts General Hospital
Cardiology
Dr. Robert E. Gerszten, MD
|
|
Give Review
Doctor Robert E. Gerszten, MD is an expert in the field of Cardiology. He attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He over the years received 1 awards: "Elected Member". Dr. Robert E. Gerszten has written publications. He has 98 publications published with PubMed. The lastest publication is: 'Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis.' Robert E. Gerszten accepts Medicare payments and is registered with Medicare.gov.
Publications
- Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.
- Metabolomic profiling in the prediction of gestational diabetes mellitus.
- Genetic architecture of insulin resistance in the mouse.
- PTPMT1 Inhibition Lowers Glucose through Succinate Dehydrogenase Phosphorylation.
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.
- Metabolite Traits and Genetic Risk Provide Complementary Information for the Prediction of Future Type 2 Diabetes.
- β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.
- Pharmacological Inhibition of a MicroRNA Family in Nonhuman Primates by a Seed-Targeting 8-Mer AntimiR.
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
- Branched chain and aromatic amino acids change Acutely following two medical therapies for type 2 diabetes mellitus.
- A combined epidemiologic and metabolomic approach improves CKD prediction.
- A Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort.
- Toward new biomarkers of cardiometabolic Diseases.
- Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy.
- Metabolite Profiling Identifies a Branched Chain Amino Acid Signature in Acute Cardioembolic Stroke.
- Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol are Associated with Monocytosis and Atherosclerosis.
- Metabolite Profiles During Oral Glucose Challenge.
- Relationship between postprandial metabolomics and colon motility in children with constipation.
- Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.
- An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of action.
- Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure.
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients treated with Anthracyclines, Taxanes and Trastuzumab.
- Targeted metabolomics.
- Programming human pluripotent stem cells into white and brown adipocytes.
- Metabolomics and Cardiovascular Biomarker Discovery.
- Status and prospects for discovery and verification of new biomarkers of cardiovascular Disease by proteomics.
- Aortic Aneurysm Generation in Mice With Targeted Deletion of Integrin-Linked Kinase in Vascular Smooth Muscle Cells.
- Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay insights from a Coronary sinus sampling study.
- Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
- Two roads diverge: weight loss interventions and circulating amino acids.
- Detection of macrophages in Aortic aneurysms by nanoparticle positron emission tomography-computed tomography.
- Metabolite profiles and the risk of developing diabetes.
- Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.
- A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular Disease.
- MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.
- Metabolite profiling identifies markers of uremia.
- Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation ...
- Metabolic signatures of exercise in human plasma.
- Toward metabolomic signatures of cardiovascular Disease.
- Interpreting metabolomic profiles using unbiased pathway models.
- Integration of proteomic-based tools for improved biomarkers of Myocardial injury.
- Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.
- Vascular effects of a low-carbohydrate high-protein diet.
- Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.
- Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry.
- New antibody assays for cardiovascular Disease: future tools for the clinical chemist?
- Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against Aneurysm formation and rupture.
- Metabolite profiling of blood from individuals undergoing planned Myocardial infarction reveals early markers of Myocardial injury.
- Novel antibody markers of unstable atherosclerotic lesions.
- Application of metabolomics to cardiovascular biomarker and pathway discovery.
- Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
- Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation Myocardial infarction.
- Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions.
- Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary Pulmonary hypertension.
- Inhibited Aortic aneurysm formation in BLT1-deficient mice.
- SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration.
- Alpha-actinin-4 is required for normal podocyte adhesion.
- Biomarker discovery and validation.
- Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
- Metabolomic identification of novel biomarkers of Myocardial ischemia.
- Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival.
- Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment.
- Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma.
- Integrin-linked kinase regulates endothelial cell survival and vascular development.
- Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells.
- Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment.
- Mechanisms of leukotriene B4--triggered monocyte adhesion.
- Mice deficient in alpha-actinin-4 have severe glomerular Disease.
- In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe.
- Role of integrin-linked kinase in leukocyte recruitment.
- Pleiotropic effects of chemokines in vascular lesion development.
- IKKβ regulates essential functions of the vascular endothelium through kinase-dependent and -independent pathways.
- Performance characteristics of an FT MS-based workflow for label-free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigat...
- A novel near-infrared fluorescence sensor for detection of thrombin activation in blood.
- Endothelial IKK beta signaling is required for monocyte adhesion under laminar flow conditions.
- A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after Myocardial injury.
- Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.
- Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human...
- Pharmacological inhibition of BLT1 diminishes early abdominal Aneurysm formation.
- The search for new cardiovascular biomarkers.
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.
- A functional annotation of subproteomes in human plasma.
- On the interpretation of genetic association studies.
- Nosocomial Legionella micdadei pneumonia: 10 years experience and a case-control study.
- Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate.
- Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
- What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after Myocardial infarction?
- Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro.
- Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis.
- MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.
- C-C and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions.
- Chemokines, leukocytes, and atherosclerosis.
- Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions.
- Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism.
- Increases in myocardial workload induced by rapid Atrial pacing trigger alterations in global metabolism.
- Metabolite profiles of diabetes incidence and intervention response in the Diabetes Prevention Program.
- Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.
Schools
Johns Hopkins University School Of Medicine
University Of Pennsylvania
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Elected Member
Education
-
University of Pennsylvania Health System -
Johns Hopkins University School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1235184573 | |
| NPPES Provider LastName | GERSZTEN | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 021142620 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 124.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235184573 |
| Last Name Of The Provider | GERSZTEN |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Calum A. MacRae, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katharine O. Stansmore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. O Donnell, MD |
|
|
Dr. Rahul Kakkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin A. Olenchock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter G. Sanchez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey Popma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garrick C. Stewart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajat S. Barua, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adeeb H. Al-Quthami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wilson S. Colucci, MD
This Doctor is OpenDoctor Recommended.
|